[1]
Pratt DP. Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements: A Comprehensive Review of Epidemiology, Pathophysiology, Diagnosis and Treatment Considerations. Current rheumatology reviews. 2016:12(2):91-112
[PubMed PMID: 26902775]
[2]
. Restless legs syndrome: detection and management in primary care. National Heart, Lung, and Blood Institute Working Group on Restless Legs Syndrome. American family physician. 2000 Jul 1:62(1):108-14
[PubMed PMID: 10905782]
[3]
Evidente VG, Adler CH. How to help patients with restless legs syndrome. Discerning the indescribable and relaxing the restless. Postgraduate medicine. 1999 Mar:105(3):59-61, 65-6, 73-4
[PubMed PMID: 10086034]
[4]
Cesnik E, Casetta I, Turri M, Govoni V, Granieri E, Strambi LF, Manconi M. Transient RLS during pregnancy is a risk factor for the chronic idiopathic form. Neurology. 2010 Dec 7:75(23):2117-20. doi: 10.1212/WNL.0b013e318200d779. Epub
[PubMed PMID: 21135386]
Level 3 (low-level) evidence
[5]
Takaki J, Nishi T, Nangaku M, Shimoyama H, Inada T, Matsuyama N, Kumano H, Kuboki T. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003 Apr:41(4):833-9
[PubMed PMID: 12666070]
[6]
Kutner NG, Zhang R, Huang Y, Bliwise DL. Racial differences in restless legs symptoms and serum ferritin in an incident dialysis patient cohort. International urology and nephrology. 2012 Dec:44(6):1825-31. doi: 10.1007/s11255-011-0108-6. Epub 2012 Jan 5
[PubMed PMID: 22219175]
[7]
Prosperetti C, Manconi M. Restless Legs Syndrome/Willis-Ekbom Disease and Pregnancy. Sleep medicine clinics. 2015 Sep:10(3):323-9, xiv. doi: 10.1016/j.jsmc.2015.05.016. Epub 2015 Jun 22
[PubMed PMID: 26329442]
[8]
Gupta R, Dhyani M, Kendzerska T, Pandi-Perumal SR, BaHammam AS, Srivanitchapoom P, Pandey S, Hallett M. Restless legs syndrome and pregnancy: prevalence, possible pathophysiological mechanisms and treatment. Acta neurologica Scandinavica. 2016 May:133(5):320-9. doi: 10.1111/ane.12520. Epub 2015 Oct 19
[PubMed PMID: 26482928]
[9]
Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, Pantzaris MC, Stefanidis I, Sakkas GK. Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review. Kidney international. 2014 Jun:85(6):1275-82. doi: 10.1038/ki.2013.394. Epub 2013 Oct 9
[PubMed PMID: 24107848]
[10]
Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 May:43(5):763-71
[PubMed PMID: 15112166]
[11]
Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep medicine. 2003 Mar:4(2):121-32
[PubMed PMID: 14592342]
Level 1 (high-level) evidence
[12]
Weinstock LB, Walters AS, Paueksakon P. Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms. Sleep medicine reviews. 2012 Aug:16(4):341-54. doi: 10.1016/j.smrv.2011.09.003. Epub 2012 Jan 17
[PubMed PMID: 22258033]
[14]
Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. 2001 Mar:18(2):128-47
[PubMed PMID: 11435804]
[15]
Askenasy N, Askenasy JJ. Restless Leg Syndrome in Neurologic and Medical Disorders. Sleep medicine clinics. 2015 Sep:10(3):343-50, xv. doi: 10.1016/j.jsmc.2015.05.008. Epub 2015 Jul 2
[PubMed PMID: 26329444]
[16]
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep medicine. 2014 Aug:15(8):860-73. doi: 10.1016/j.sleep.2014.03.025. Epub 2014 May 17
[PubMed PMID: 25023924]
Level 3 (low-level) evidence
[19]
Dauvilliers Y, Benes H, Partinen M, Rauta V, Rifkin D, Dohin E, Goldammer N, Schollmayer E, Schröder H, Winkelman JW. Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2016 Sep:68(3):434-43. doi: 10.1053/j.ajkd.2015.12.027. Epub 2016 Feb 3
[PubMed PMID: 26851201]
Level 1 (high-level) evidence
[20]
Liu GJ, Wu L, Lin Wang S, Xu LL, Ying Chang L, Fu Wang Y. Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Clinical therapeutics. 2016 Jan 1:38(1):162-179.e6. doi: 10.1016/j.clinthera.2015.10.010. Epub 2015 Nov 11
[PubMed PMID: 26572941]
Level 1 (high-level) evidence
[21]
Zintzaras E, Kitsios GD, Papathanasiou AA, Konitsiotis S, Miligkos M, Rodopoulou P, Hadjigeorgiou GM. Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis. Clinical therapeutics. 2010 Feb:32(2):221-37. doi: 10.1016/j.clinthera.2010.01.028. Epub
[PubMed PMID: 20206780]
Level 2 (mid-level) evidence
[22]
Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Högl B, Manconi M, Montplaisir J, Inoue Y, Allen RP. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep medicine. 2013 Jul:14(7):675-84. doi: 10.1016/j.sleep.2013.05.016. Epub
[PubMed PMID: 23859128]
Level 3 (low-level) evidence
[23]
Grote L, Leissner L, Hedner J, Ulfberg J. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Movement disorders : official journal of the Movement Disorder Society. 2009 Jul 30:24(10):1445-52. doi: 10.1002/mds.22562. Epub
[PubMed PMID: 19489063]
Level 1 (high-level) evidence
[24]
Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Archives of internal medicine. 2004 Jan 26:164(2):196-202
[PubMed PMID: 14744844]
[25]
Abetz L, Allen R, Follet A, Washburn T, Earley C, Kirsch J, Knight H. Evaluating the quality of life of patients with restless legs syndrome. Clinical therapeutics. 2004 Jun:26(6):925-35
[PubMed PMID: 15262463]
Level 2 (mid-level) evidence
[26]
McCullagh MC. Restless Legs Syndrome Negatively Impacts Worker Health and Safety. Workplace health & safety. 2018 Jul:66(7):360. doi: 10.1177/2165079918781878. Epub 2018 Jun 13
[PubMed PMID: 29897020]